| Trial ID: | L3903 |
| Source ID: | NCT00642538
|
| Associated Drug: |
Mkc253 Inhalation Powder
|
| Title: |
A Study Designed to Determine the Safety and Pharmacological Response ofMKC253 Inhalation Powder in Adults With Type 2 Diabetes Mellitus
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: MKC253 Inhalation Powder|DRUG: Technosphere Inhalation Powder|DRUG: subcutaneous injection
|
| Outcome Measures: |
Primary: AUC 0-240 min post-prandial serum glucose, 240 minutes |
|
| Sponsor/Collaborators: |
Sponsor: Mannkind Corporation
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
20
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2008-02
|
| Completion Date: |
2008-09
|
| Results First Posted: |
|
| Last Update Posted: |
2012-06-14
|
| Locations: |
University Medical Centre Groningen, Zuidlaren, 9470 AE, Netherlands
|
| URL: |
https://clinicaltrials.gov/show/NCT00642538
|
